Application for quotation of securities - BLS

Sep 10, 2026 at 2:36 AM EDT · Issued by BLS Pharmaceuticals Limited via ASX

Filed with ASX · Sep 10, 2026 at 2:36 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-bls-3

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameBLS PHARMACEUTICALS LIMITEDAnnouncement TypeNew announcementDate of this announcementThursday September 10, 2026The +securities to be quoted are:Total number...

View Attachment

6ix hasn’t read this filing yet.

BLS Pharmaceuticals Limited on 6ix

Earlier from BLS Pharmaceuticals

S&P DJI Announces September 2026 Quarterly RebalanceSep 4
Appendix 4G Corporate Governance StatementAug 31
BLS FY2027 GuidanceAug 30
BLS Investor PresentationAug 30
BLS FY2026 Results AnnouncementAug 30

Later from BLS Pharmaceuticals

Angus Walker Appointed Alternate Director to Edward MyerSep 13
Initial Director's Interest NoticeSep 14
AGM Date and Director NominationsOct 6
Becoming a substantial holderOct 8
Ceasing to be a substantial holderOct 12

All BLS Pharmaceuticals news releases

Follow BLS Pharmaceuticals into a list and get an email when it puts out news.

Follow BLS Pharmaceuticals